ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
•31 Jan 2017 22:29

Korea Stock Market Monthly Recap #10 - (January 2017)

The Trump economic hope continued to positively impact emerging markets, including Korea. KOSPI was up 2% in January 2017, versus our model...

Logo
471 Views
Share
•30 Jan 2017 09:45

Whale Watching in the Korea Stock Market

There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...

Logo
365 Views
Share
bearish•Celltrion Inc
•20 Jan 2017 20:59

Recent Developments Not Encouraging

This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...

Share
bullish•Eubiologics
•13 Jan 2017 00:29

Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View

Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...

Logo
584 Views
Share
bullish•Eubiologics
•10 Jan 2017 16:02

Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...

Logo
326 Views
Share
x